Your session is about to expire
← Back to Search
Study Summary
This trial will assess patient adherence and feelings on a novel web-based visual field test over 6 months. Participants will use iPads to complete tests at home, with researchers sending reminders and returning to the office to compare results.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition that affects my central vision.I do not speak English.I am physically unable to perform certain medical tests.I am between 18-100 years old and may have glaucoma.
- Group 1: Single Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research initiative recruiting participants aged 55 and above?
"According to the inclusion criteria, applicants aged between 18 - 100 are eligible for this medical trial. Furthermore, there are 22 specific studies targeting younger individuals and 189 that focus on elderly patients."
How many participants has this medical trial recruited thus far?
"Verified. Data from clinicaltrials.gov reveals that the medical trial, initially posted on March 1st 2023, is still actively recruiting participants to join. A total of 50 patients must be recruited across one centre for this study to reach completion."
What goals does this investigation have in mind?
"The primary outcome monitored in this trial over a six month period is EyeSimplify Self-Test Persistence. Secondary outcomes include Visual Field Reliability Metric #2 - False Negative Rate (defined as when a subject fails to record a response to an expected stimulus), Visual Field Reliability Metric #3 - Fixation Loss Rate (when the patient records a response to stimuli presented in their physiologic blind spot, indicating lack of fixation) and Visual Field Performance Metric #1 – Mean Deviation (the center-weighted average of decibel deviations at each point tested)."
What criteria must participants meet in order to take part in this trial?
"This clinical trial requires 50 patients of ages 18-100, suspected to suffer from glaucoma ranging in severity. The necessary criteria for applicants is a diagnosis or suspicion of the eye condition within this age range."
Are there any opportunities to join this research endeavor?
"According to clinicaltrials.gov, this research is actively recruiting participants. The initial posting was made on the 3rd of January 2023 and most recently revised on the 9th of January 2023."
Share this study with friends
Copy Link
Messenger